Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm
Investor Alert: Bragar Eagel & Squire, P.C. is investigating potential claims against Semler, GoHealth, Adtran, and Fulgent for possible violations of federal securities laws, encouraging affected investors to contact their attorneys for legal options.
Company-Specific Issues: Each company has faced significant legal challenges, including investigations by the U.S. Department of Justice and issues with financial reporting, leading to notable declines in their stock prices following these disclosures.
Trade with 70% Backtested Accuracy
Analyst Views on GOCO
About GOCO
About the author
GoHealth (GOCO) Announces Q3 Loss, Falls Short of Revenue Projections
Quarterly Performance: GoHealth reported a quarterly loss of $0.19 per share, significantly better than the expected loss of $2.06, marking a 90.78% earnings surprise. However, revenues of $34.19 million fell short of estimates by 67.05%.
Stock Performance: GoHealth shares have declined approximately 74.3% year-to-date, contrasting with a 16.5% gain in the S&P 500, raising concerns about the company's future stock performance.
Earnings Outlook: The current consensus EPS estimate for the upcoming quarter is $1.92, with revenues projected at $380.13 million. The stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Insurance - Life Insurance industry is currently in the top 20% of Zacks-ranked industries, suggesting that broader industry trends could significantly influence GoHealth's stock performance moving forward.
Brighthouse Financial (BHF) Rises 27.2%: Is There More Growth Potential for the Stock?
Brighthouse Financial Stock Surge: Brighthouse Financial (BHF) shares surged 27.2% to $57.59, driven by acquisition news from Aquarian Holdings and increased trading volume, contrasting with a 2.5% loss over the past month.
Growth and Earnings Outlook: The company is focusing on enhancing its life insurance and annuity products, with expected quarterly earnings of $5.06 per share, reflecting a 26.8% year-over-year increase, and a revenue forecast of $2.25 billion, up 3.3% from last year.
